Iron Deficiency in Pulmonary Hypertension.

Area of Science:

• Cardiovascular Medicine
• Pulmonary Medicine
• Hematology

Background:

• Pulmonary hypertension (PH) is a serious condition with high morbidity and mortality.
• Iron deficiency is a prevalent and often overlooked factor in PH pathophysiology.
• Iron deficiency is associated with diminished exercise capacity and impaired cardiac function in PH patients.

Purpose of the Study:

• To review the prevalence and implications of iron deficiency in PH.
• To analyze the therapeutic potential of addressing iron deficiency in PH.
• To discuss the complexities of iron metabolism and supplementation in PH management.

Main Methods:

• Critical analysis of recent clinical trials and studies on iron supplementation in PH.
• Review of evidence on oral and intravenous iron repletion.
• Discussion of pathophysiological mechanisms linking iron deficiency and PH.

Main Results:

• Iron deficiency is prevalent in a significant proportion of PH patients.
• Iron supplementation shows variable effects on exercise capacity and hemodynamics in PH.
• Challenges exist in diagnosing and treating iron deficiency in this population.

Conclusions:

• Recognizing and managing iron deficiency is crucial for PH patients.
• Further research is needed to establish evidence-based guidelines for iron supplementation in PH.
• Personalized treatment approaches are essential for improving outcomes in PH.